GLPBio

PI3K/Akt/mTOR Signaling

Research Areas

Products Related to PI3K/Akt/mTOR Signaling(719)

  • GC33765 structure
    GC33765Palmitelaidic Acid (9-trans-Hexadecenoic acid)
    CAS: 10030-73-6
    Purity: >98.00%

    Palmitelaidic Acid (9-trans-Hexadecenoic acid) is a trans isomer of palmitoleic acid and dietary fatty acid that has been found in dairy fat products and various partially hydrogenated oils.

  • GC34053 structure
    GC34053SOLENOPSIN
    CAS: 137038-57-4
    Purity: >98%

    Solenopsin is an ATP-competitive AKT inhibitor with IC50 value of 10 μM .

  • GC34121 structure
    GC34121CC-115 hydrochloride
    CAS: 1300118-55-1
    Purity: >98.00%

    CC-115 hydrochloride is a potent and dual DNA-PK and mTOR kinase inhibitor with IC50s of 13 nM and 21 nM, respectively. CC-115 blocks both mTORC1 and mTORC2 signaling.

  • GC34909 structure
    GC34909JR-AB2-011
    CAS: 2411853-34-2
    Purity: >98.50%

    JR-AB2-011 is an improved mTORC2 inhibitor identified through structure-activity relationship (SAR) studies with an IC 50 value of 0.36μM.

  • GC35037 structure
    GC350371,3-Dicaffeoylquinic acid
    CAS: 19870-46-3
    Purity: >98.50%

    1,3-Dicaffeoylquinic acid inhibits the 3' end processing, terminal connection, and disintegration process of HIV-1 integrase, with IC 50 values of 0.35, 0.56, and 0.84μg/ml respectively.

  • GC35124 structure
    GC351243α-Hydroxymogrol
    CAS: 1343402-73-2
    Purity: >98.00%

    3α-Hydroxymogrol is a triterpenoid isolated from Siraitia grosvenorii Swingle, acts as a potent AMPK activator, and enhances AMPK phosphorylation.

  • GC35162 structure
    GC351625-Iodo-indirubin-3'-monoxime
    CAS: 331467-03-9
    Purity: >99.50%

    5-Iodo-indirubin-3'-monoxime is a potent GSK-3β, CDK5/P25 and CDK1/cyclin B inhibitor, competing with ATP for binding to the catalytic site of the kinase, with IC50s of 9, 20 and 25 nM, respectively.

  • GC35212 structure
    GC35212A-674563 hydrochloride
    CAS: 2070009-66-2
    Purity: >98.00%

    A-674563 hydrochloride is an orally active Akt inhibitor (K i =11nM).

  • GC35242 structure
    GC35242Actein
    CAS: 18642-44-9
    Purity: >98.50%

    Actein is a triterpene glycoside isolated from the rhizomes of Cimicifuga foetida. Actein suppresses cell proliferation, induces autophagy and apoptosis through promoting ROS/JNK activation, and blunting AKT pathway in human bladder cancer. Actein has little toxicity in vivo.

  • GC35275 structure
    GC35275AKT-IN-3
    CAS: 2374740-21-1
    Purity: >98%

    AKT-IN-3 (compound E22) is a potent, orally active low hERG blocking Akt inhibitor, with 1.4 nM, 1.2 nM and 1.7 nM for Akt1, Akt2 and Akt3, respectively. AKT-IN-3 (compound E22) also exhibits good inhibitory activity against other AGC family kinases, such as PKA, PKC, ROCK1, RSK1, P70S6K, and SGK. AKT-IN-3 (compound E22) induces apoptosis and inhibits metastasis of cancer cells.

  • GC35327 structure
    GC35327AMPK activator 1
    CAS: 1152423-98-7
    Purity: >98.50%

    AMPK activator 1 is an AMPK activator extracted from patent WO2013116491A1, compound No.1-75, has an EC50 of <0.1μM.

  • GC35395 structure
    GC35395Arnicolide D
    CAS: 34532-68-8
    Purity: >98.00%

    Arnicolide D is a sesquiterpene lactone isolated from Centipeda minima. Arnicolide D modulates the cell cycle, activates the caspase signaling pathway and inhibits the PI3K/AKT/mTOR and STAT3 signaling pathways. Arnicolide D inhibits Nasopharyngeal carcinoma (NPC) cell viability in a concentration- and time-dependent manner.

  • GC35509 structure
    GC35509BGT226
    CAS: 915020-55-2
    Purity: >98%

    BGT226 (NVP-BGT226) is a PI3K (with IC50s of 4 nM, 63 nM and 38 nM for PI3Kα, PI3Kβ and PI3Kγ)/mTOR dual inhibitor which displays potent growth-inhibitory activity against human head and neck cancer cells.

  • GC35579 structure
    GC35579CAL-130
    CAS: 1431697-74-3
    Purity: >98%

    CAL-130 is a PI3Kδ and PI3Kγ inhibitor with IC50s of 1.3 and 6.1 nM, respectively.

  • GC35580 structure
    GC35580CAL-130 Racemate
    CAS: 474012-90-3
    Purity: >98%

    CAL-130 Racemate is the racemate of CAL-130. CAL-130 Racemate is a PI3Kδ inhibitor.

  • GC35651 structure
    GC35651Cenisertib
    CAS: 871357-89-0
    Purity: >99.50%

    Cenisertib (AS-703569) is an ATP-competitive multi-kinase inhibitor that blocks the activity of Aurora-kinase-A/B, ABL1, AKT, STAT5 and FLT3. Cenisertib induces major growth-inhibitory effects by blocking the activity of several different molecular targets in neoplastic mast cells (MC). Cenisertib inhibits tumor growth in xenograft models of pancreatic, breast, colon, ovarian, and lung tumors and leukemia.

  • GC35747 structure
    GC35747Crebanine
    CAS: 25127-29-1
    Purity: >99.50%

    Crebanine, an alkaloid from Stephania venosa, induces G1 arrest and apoptosis in human cancer cells.

  • GC36178 structure
    GC36178Gomisin J
    CAS: 66280-25-9
    Purity: >99.00%

    A lignan with diverse biological activities

  • GC36186 structure
    GC36186GS-9901
    CAS: 1640247-87-5
    Purity: >98%

    GS-9901 is a highly selective and orally active PI3Kδ inhibitor, with an IC50 of 1 nM.

  • GC36190 structure
    GC36190GSK-3 inhibitor 1
    CAS: 603272-51-1
    Purity: >98.00%

    GSK-3 inhibitor 1 is an inhibitor of GSK-3.

  • GC36193 structure
    GC36193GSK-3β inhibitor 1
    CAS: 187325-53-7
    Purity: >98.00%

    GSK-3β inhibitor 1 (compound 3a) is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy, with an IC50 of 4.9 nM.

  • GC36312 structure
    GC36312Indirubin-3'-monoxime-5-sulphonic acid
    CAS: 331467-05-1
    Purity: >98%

    Indirubin-3'-monoxime-5-sulphonic acid is a potent and selective inhibitor of CDK1, CDK5, and GSK-3β with IC50s of 5 nM, 7 nM, and 80 nM, respectively.

  • GC36313 structure
    GC36313Indirubin-5-sulfonate
    CAS: 244021-67-8
    Purity: >98%

    Indirubin-5-sulfonate is a cyclin-dependent kinase (CDK) inhibitor, with IC50 values of 55 nM, 35 nM, 150 nM, 300 nM and 65 nM for CDK1/cyclin B, CDK2/cyclin A, CDK2/cyclin E, CDK4/cyclin D1, and CDK5/p35, respectively. Indirubin-5-sulfonate also shows inhibitory activity against GSK-3β.

  • GC36426 structure
    GC36426LAS191954
    CAS: 1403947-26-1
    Purity: >98%

    LAS191954 is a potent, selective and orally active PI3Kδ inhibitor for inflammatory diseases treatment, with an IC50 of 2.6 nM.